Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A
Von Willebrand factor (VWF) has been proposed to reduce the immunogenicity of therapeutic factor VIII (FVIII) in patients with hemophilia A. Using FVIII-deficient mice, we compared the immunogenicity of different preparations of plasma-derived (pd) and recombinant (r) FVIII. Treatment of mice with p...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Ferrata Storti Foundation
2007-10-01
|
Series: | Haematologica |
Online Access: | https://haematologica.org/article/view/4611 |